Blog

TotipotentRX & ThermoGenesis Case Study Demonstrates Autologous Stem …
MarketWatch
Mr. Ken Harris, Study Director and Chief Executive Officer of TotipotentRX, presented a case study and physician feedback confirming that the Company’s Acute Myocardial Infarction Rapid Stem Cell Therapy (“AMIRST”) protocol utilizing autologous bone …

and more